Novartis renews WHO medicine donation pledge with aim of ending leprosy
Novartis leprosy medicine donation program with WHO extended to 2025 Program has already treated over 7 million patients since 2000 New evidence from contact tracing and preventive treatment program shows route to accelerate elimination Basel, January 29, 2021 — A renewed partnership agreement signed by Novartis and the World Health Organization (WHO) will drive the …
Novartis renews WHO medicine donation pledge with aim of ending leprosy Read More »
